Pharmacist-led care can contribute to improved clinical outcomes and reduced long term health risks for people living with certain conditions, decreasing the burden of disease for both individuals and the health-care system.
Pharmacists who have completed the necessary requirements may prescribe drugs, treatments or devices for conditions listed under the Common Ailments, Preventable Conditions, and Chronic Conditions sections below. Pharmacists must take the necessary steps to ensure competency and ensure they are able to recognize when the signs, symptoms and health needs of the patient require referral or emergency medical treatment. Practice authorizations are noted next to the pharmacist’s name and registration number in the College’s public register.
Last updated: November 2026.
Common Ailments
Pharmacists may prescribe Schedule I, Schedule II, Schedule III and Unscheduled medications for the treatment of the following. Contents of this list of Common Ailments reflects what was in the first Section of Appendix 2 to the Regulations, prior to May, 2025.
- Acute Bacterial Rhinosinusitis
- Allergic Rhinitis
- Calluses and Corns
- Conjunctivitis (allergic and bacterial)
- Contact Allergic Dermatitis
- Dandruff
- Dysmenorrhea
- Dyspepsia
- Ear Infections in the Middle and External Ear
- Emergency Contraception
- Fungal Infections of the Skin
- Gastro-esophageal Reflux Disease
- Group A streptococcal (GAS) pharyngitis (Guidance)
- Hemorrhoids
- Herpes Simplex
- Herpes Zoster (shingles) (Guidance)
- Impetigo
- Mild Acne
- Mild Headache
- Mild to Moderate Eczema
- Mild Urticaria (including bites and stings)
- Minor Joint Pain
- Minor Muscle Pain
- Minor Sleep Disorders
- Nausea
- Nicotine dependence
- Non-infectious Diarrhea
- Oral Fungal Infection (thrush)
- Oral Ulcers
- Severe Acute Respiratory Syndrome (SARS)
- Threadworms and Pinworms
- Upper respiratory tract symptoms (cough, nasal congestion and discharge, sore throat, fever, malaise)
- Urinary Tract Infection (uncomplicated)
- Vaginal Candidiasis
- Warts (excluding facial and genital)
- Xerophthalmia (dry eyes)
Preventable Conditions
Pharmacists may prescribe Schedule I, Schedule II, Schedule III and Unscheduled vaccines (individual or combination products) and/or drug products for the prevention of the following. Contents of this list of preventable conditions reflects what was in the second section of Appendix 2 to the Regulations, prior to May, 2025.
- Cholera (pharmacist may prescribe only the oral vaccine)
- Diphtheria
- Haemophilus influenzae type B
- Hepatitis A
- Hepatitis B
- Herpes Zoster (shingles)
- Human Papillomavirus (HPV)
- Lyme Disease (Guidance)
- Malaria
- Measles
- Meningococcal disease
- Mumps
- Pertussis
- Pneumococcal Disease
- Polio
- Pregnancy (oral, transdermal, transvaginal and injection hormonal drug products) (Guidance)
- Respiratory Syncytial Virus (RSV) (Guidance)
- Rubella
- Seasonal Influenza
- Severe Acute Respiratory Syndrome (SARS)
- Tetanus
- Traveler’s Diarrhea (pharmacist may also prescribe pre-emptive treatment)
- Varicella zoster (chickenpox)
Pharmacists may only prescribe Schedule I, Schedule II, Schedule III and Unscheduled vaccines (individual or combination products) and/or drug products for the prevention of the following travel-related diseases upon successful completion of a training program in travel medicine approved by Council. (The initial list of preventable conditions appeared in Appendix 2 to the Regulations prior to May 2025)
- Altitude Sickness
- Chikungunya
- Cholera (other than the oral vaccine)
- European tick-borne encephalitis
- Japanese encephalitis
- Rabies
- Typhoid
- Yellow fever
Chronic Conditions
For the chronic conditions listed below, an authorized pharmacist may initiate or adjust medication therapy when:
- The condition has previously been identified by a primary care provider or specialist, and the pharmacist's assessment supports treatment; or
- The pharmacist's assessment, supported by current clinical practice guidelines, indicates that treatment is appropriate.
In either circumstance, the pharmacist must have sufficient clinical information, practise within their competence, and ensure appropriate monitoring and follow-up.
Pharmacists may assess and prescribe treatment for the following conditions ONLY if authorization is received from the College and they have already been granted laboratory access.
- Asthma
- Cardiovascular Disease
- Chronic Obstructive Pulmonary (COPD)
- Diabetes
- Obesity (November 2026)
Resources for Pharmacists - Obesity
A three-part, CCCEP-accredited webinar series to build confidence in supporting patients living with obesity. Treatment options and practical strategies for respectful, patient-centered conversations about chronic weight management in community pharmacy.
- Webinar series: Chronic Weight Management (CPhA) https://www.pharmacists.ca/advocacy/cphalearning/webinar-series-chronic-weight-management/
- From Bias to Best Practice: Empowering Pharmacists to Assess and Manage Obesity as a Chronic Disease (NBPA featuring Mike Boivin) https://nbpharma.memberlounge.app/resources/from-bias-to-best-practice-empowering-pharmacists-to-assess-and-manage-obesity-as-a-chronic-disease
- Adult Obesity: Managing Chronic Disease (PANS) https://pans.memberlounge.app/resources/adult-obesity-managing-chronic-disease
- Clinical practice guidelines and education hub (Obesity Canada) https://obesitycanada.ca/healthcare-professionals/adult-clinical-practice-guideline/
Pharmacy Research or Pilot Projects Framework
The College accepts submissions for research or pilot projects designed to evaluate pharmacist-led assessment and prescribing in expanded pharmacy services for the public. The framework is in accordance with the Regulations and is provided in detail in the following guidance and supporting documents:
Guidance for Prescribing in Accordance with a Research or Pilot Protocol:
Guidance Documents
- Guidance: Assessing and Prescribing for Contraception Management
- Guidance: Assessing and Prescribing for Ear Infections and Acute Bacterial Rhinosinusitis
- Guidance: Assessing and Prescribing for Group A Streptococcal (GAS) Pharyngitis
- Guidance: Assessing and Prescribing for Lyme Disease Prophylaxis
- Guidance: Assessing and Prescribing for Treatment of Herpes Zoster (Shingles)